GOLDENWELL BIOTECH, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

GOLDENWELL BIOTECH, INC. reported Cash And Cash Equivalents At Carrying Value of $46.0 thousand for the year ending 2022.

  • GOLDENWELL BIOTECH, INC. showed a decrease of -78.5% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from GOLDENWELL BIOTECH, INC.'s annual report (Form 10-K), filed with the SEC on April 13, 2023.
  • XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2022: $46.0 thousand | Fiscal year 2021: $213.6 thousand | Fiscal year 2020: $248.6 thousand | Fiscal year 2019: $246.6 thousand | Fiscal year 2018: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: